TRJ ASX Week ended 07 Aug 2026

Weekly Investor Report

Trajan Group Holdings Limited · Healthcare · Medical Instruments & Supplies

Latest close 0.20 AUD
-4.9% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -52.0% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned -4.9%, after a -32.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.

Setup score 17 out of 100
Latest Close 0.20 AUD 7 Aug 2026
1W Return -4.9% latest completed week
4W Return -32.8% short-term follow-through
12W Return -44.3% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -52.0% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned -4.9%, after a -32.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1712-week average 0.11

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.17Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -32.8% over four weeks, -44.3% over 12 weeks, and -79.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-4.9%
4W-32.8%
12W-44.3%
26W-71.1%
52W-79.3%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.28Latest activity-pressure read.
Pressure change0.6%Four-week change in activity pressure.
Leadership-66.49Latest relative-leadership reading.
RS change-28.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 30 Jun 2025 Field coverage 76% Model confidence 39%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength10/100Blend of value, momentum, and quality. Underlying universe rank 91; rank 1 is best.
Value24/100Relative valuation strength. Underlying universe rank 77; rank 1 is best.
Quality22/100Profitability and accounting quality. Underlying universe rank 79; rank 1 is best.
Momentum23/100Medium-term price momentum. Underlying universe rank 78; rank 1 is best.
Growth24/100Revenue and earnings growth. Underlying universe rank 77; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework27/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.2x
Market value relative to trailing revenue.
EV / EBITDA
9.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
38.1%
Gross profit retained from each unit of revenue.
Operating margin
2.1%
Operating profit retained from revenue.
Free-cash-flow margin
4.1%
Free cash flow generated from revenue.
Return on invested capital
1.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
7.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
4.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
5.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 19 relevant articles.

2 positive · 17 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-79.4%Distance below the 52-week high.
13-week volatility16.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher5 of 2621 weeks finished lower.
Best week+40.0%Week of 3 Jul.
Worst week-24.5%Week of 26 Jun.
Latest week-4.9%Week of 7 Aug.

Shape of recent returns

Strong gains3
Modest gains2
Flat weeks0
Modest losses6
Sharp losses15
Recent vol16.1%13-week weekly-return volatility.
Base vol9.4%52-week weekly-return volatility.
Up/down split17/34Count of positive and negative weeks in the 52-week window.
Average skew6.6% / -7.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20260.20 AUD-4.9%0.41 AUD0.89 AUD-0.28-66.49416.1KOff
31 Jul 20260.20 AUD-2.4%0.42 AUD0.90 AUD-0.15-64.57526.2KOff
24 Jul 20260.21 AUD-14.3%0.44 AUD0.91 AUD-0.07-63.571.2MOff
17 Jul 20260.24 AUD-15.5%0.45 AUD0.92 AUD-0.18-58.41140.5KOff
10 Jul 20260.29 AUD3.6%0.47 AUD0.93 AUD-0.28-51.62314.9KOff
3 Jul 20260.28 AUD40.0%0.48 AUD0.94 AUD-0.35-54.17396.2KOff
26 Jun 20260.20 AUD-24.5%0.49 AUD0.95 AUD-0.59-67.441.1MOff
19 Jun 20260.27 AUD-18.5%0.51 AUD0.96 AUD-0.69-57.90104.6KOff
12 Jun 20260.33 AUD3.2%0.52 AUD0.97 AUD-0.80-48.99367.5KOff
5 Jun 20260.32 AUD-6.0%0.53 AUD0.98 AUD-1.00-50.1325.9KOff
29 May 20260.34 AUD13.6%0.55 AUD0.99 AUD-0.99-48.26582.3KOff
22 May 20260.29 AUD-15.7%0.56 AUD0.99 AUD-1.15-54.69372.5KOff
15 May 20260.35 AUD-2.8%0.58 AUD1.00 AUD-1.11-47.09600.4KOff
8 May 20260.36 AUD-4.0%0.60 AUD1.01 AUD-1.22-47.24254.2KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context